New CGFNS Survey of Immigrant Nurses in the U.S. Reveals Their Economic Impact
PHILADELPHIA, PA, Aug 16, 2023 – (ACN Newswire) – In addition to helping alleviate a…
Month: August 2023
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Discover Financial Services (DFS) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Verily and OneOncology Announce Collaboration to Advance Cancer Research
The partnership will provide community OneOncology Research Network sites with new tools to accelerate clinical…
Avangrid Pioneers In-House Creation of Artificial Intelligence to Increase Reliability
Machine learning models will allow CMP, NYSEG, RG&E and UI to forecast grid performance ahead…
Celero Commerce Enters Partnership with Nashville’s Iconic Bluebird Cafe
Nashville Fintech Becomes Popular Music Venue’s Preferred Payments Partner NASHVILLE, Tenn.–(BUSINESS WIRE)–#BluebirdCafe—Celero Commerce (“Celero”), a…
Integrating 3D Printing Into Prototyping & Production Scenarios – An Interview With ITERATE Design And Innovation
At the recent TCT 3Sixty event in Birmingham, 3DPRINTUK ran a competition offering vouchers to…
Immix Biopharma Announces Additional NXC-201 AL Amyloidosis Clinical Data Accepted for Oral Presentation at the 20th International Myeloma Society Annual Meeting (September 27-30, Athens Greece)
LOS ANGELES, Aug. 16, 2023 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or…
Immix Biopharma Announces Additional NXC-201 AL Amyloidosis Clinical Data Accepted for Oral Presentation at the 20th International Myeloma Society Annual Meeting (September 27-30, Athens Greece)
LOS ANGELES, Aug. 16, 2023 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or…
COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors
Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with…
COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors
Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with…
PaxMedica Appoints David Hough M.D. as Chief Medical Officer
Announces Additional Management Changes; Independent Directors Now Majority of Board TARRYTOWN, NY, Aug. 16, 2023…
PaxMedica Appoints David Hough M.D. as Chief Medical Officer
Announces Additional Management Changes; Independent Directors Now Majority of Board TARRYTOWN, NY, Aug. 16, 2023…
Entera Bio to Present Two Abstracts on its First-in-Class, Once Daily Oral hPTH(1-34) Peptide Tablets (EB613) for the Treatment of Post-Menopausal Women at High Risk of Fracture at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting
JERUSALEM, Aug. 16, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
Entera Bio to Present Two Abstracts on its First-in-Class, Once Daily Oral hPTH(1-34) Peptide Tablets (EB613) for the Treatment of Post-Menopausal Women at High Risk of Fracture at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting
JERUSALEM, Aug. 16, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
Mustang Bio Announces First Data from Ongoing Multicenter Phase 1/2 Clinical Trial Evaluating MB-106 CAR-T Cell Therapy
Initial data show clinical responses from four of four indolent lymphoma patients, including complete response…
Mustang Bio Announces First Data from Ongoing Multicenter Phase 1/2 Clinical Trial Evaluating MB-106 CAR-T Cell Therapy
Initial data show clinical responses from four of four indolent lymphoma patients, including complete response…
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
BRIDGEWATER, N.J., Aug. 16, 2023 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or…
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
BRIDGEWATER, N.J., Aug. 16, 2023 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or…
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
Transformative Period Led by Acquisition of TeraImmune Company to Prioritize Development of New TI-168 Treg…
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
Transformative Period Led by Acquisition of TeraImmune Company to Prioritize Development of New TI-168 Treg…